Application no. and date | 16703620.1 (espacenet) (Federated) (European Patent Register), 20160105 | Patent/reg. no. and date | DK/EP 3242887, 20190814 | Publication date | 20171115 | Priority no. and date | US 201562101488 P, 20150109 | EP pub. no. and date |
EP 3242887 20171115 | Effective date | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | P81903545DK00E | Inventor | ALSINA-FERNANDEZ, Jorge, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, COSKUN, Tamer, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, CUMMINS, Robert Chadwick, c/o Eli Lilly and Company P. O. Box 6288
Indianapolis, Indiana 46206-6288, US, BOKVIST, Bengt Krister, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 38/26 (2006.01) , C07K 14/575 (2006.01) , C07K 14/605 (2006.01) | Title | GIP- og GLP-1-co-agonist-forbindelser | Int. application no. | US2016012124 | Int. publication no. | WO2016111971 | Related patent (certificate) | CA 2023 00005 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|